Bridge Pharmaceuticals, which helps pharma companies do drug research in China, raises $35M

Bridge Pharmaceuticals, a San Francisco company which lets pharmaceutical companies do pre-trial drug research in China, said it has raised $35 million in a third round of financing.

Granite Global Ventures led the round, which also included existing investors. Helen Wong, of Granite Global Ventures’ Shanghai office, has joined the board.

Earlier, Bridge raised at least $22 million from investors that included SRI International and WI Harper, among others.